LabGenius Secures £35 Million to Enhance ML-Driven Antibody Discovery
LabGenius, a leading drug discovery company leveraging machine learning (ML) to discover novel therapeutic antibodies, has successfully completed a £35 …
News
AstraZeneca to Establish $1.5 Billion ADC Manufacturing Facility in Singapore
AstraZeneca has announced plans to construct a $1.5 billion manufacturing facility in Singapore dedicated to producing antibody-drug conjugates (ADCs), a …
Accenture's Investment in Turbine Enhances AI-Powered Cell Simulations for Biopharma R&D
Accenture has strategically invested in Turbine, a company specializing in predictive simulation with a platform aimed at interpreting human biology. …
Insilico Medicine Initiates Phase I Clinical Trial for Novel QPCTL Inhibitor
Insilico Medicine, a biotechnology company specializing in generative artificial intelligence, has begun dosing patients in the first clinical trial for …
Veranova and Phorum.AI Partner to Deliver Generative AI Chemistry Optimization to the Pharmaceutical & Biotech Industry
Veranova and Phorum.AI have partnered to revolutionize pharmaceutical manufacturing processes using generative artificial intelligence. This collaboration combines Veranova's extensive 20-year …
Karius Gains $100M and FDA Breakthrough Designation for Genomic Pneumonia Test
Karius Inc., a leading company in genomic diagnostics for infectious diseases, announced that its Karius Test has received the FDA's …
Sartorius and NVIDIA to Develop AI Models for Stem Cell-Derived Organoids, Reducing Animal Testing in Drug Discovery
Sartorius, a leader in life sciences and bioprocessing, is expanding its collaboration with NVIDIA to enhance the development of innovative …
Nabla Bio Advances Generative Protein Design with $26M Series A Funding
Nabla Bio, a biotechnology firm specializing in generative protein design, has successfully closed a $26 million Series A financing round, …
Recursion Unveils BioHive-2, Fastest Pharma-Owned Supercomputer
Recursion Pharmaceuticals has achieved a significant milestone by completing BioHive-2, reportedly the fastest supercomputer to be wholly owned and operated …
Troubling Safety Data Overshadows Efficacy in MacroGenics' Phase 2 Study
MacroGenics, a biotechnology company, has reported concerning safety outcomes in its phase 2 trial of vobramitamab duocarmazine, a B7-H3-directed antibody-drug …
DeepMind Launches Advanced AlphaFold Model to Enhance Drug Discovery
Google DeepMind has introduced the latest version of its AlphaFold artificial intelligence model, which aims to assist scientists in designing …
Cytomos to Unveil Celledonia™ Technology at London Biotechnology Show 2024
Cytomos, a TechBio company, is gearing up to introduce attendees at the London Biotechnology Show 2024 to its latest development, …